Error message

No crossref credentials set for pnas

Morphine activates neuroinflammation in a manner parallel to endotoxin

PNAS, 17 April 2012
Vol. 109, Issue 16, p. 6325-6330
DOI: 10.1073/pnas.1200130109

Morphine activates neuroinflammation in a manner parallel to endotoxin

  1. Xiaohui Wanga,
  2. Lisa C. Loramb,c,
  3. Khara Ramosb,c,
  4. Armando J. de Jesusa,
  5. Jacob Thomasd,
  6. Kui Chenga,
  7. Anireddy Reddyb,c,
  8. Andrew A. Somogyid,
  9. Mark R. Hutchinsone,
  10. Linda R. Watkinsb,c, and
  11. Hang Yina,c,f,1
  1. aDepartment of Chemistry and Biochemistry,
  2. bDepartment of Psychology and Neuroscience,
  3. cCenter for Neuroscience, and
  4. fBiofrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309; and
  5. dDiscipline of Pharmacology and
  6. eDiscipline of Physiology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia
  1. Edited* by William F. DeGrado, University of California School of Pharmacy, San Francisco, CA, and approved March 8, 2012 (received for review January 4, 2012)

Abstract

Opioids create a neuroinflammatory response within the CNS, compromising opioid-induced analgesia and contributing to various unwanted actions. How this occurs is unknown but has been assumed to be via classic opioid receptors. Herein, we provide direct evidence that morphine creates neuroinflammation via the activation of an innate immune receptor and not via classic opioid receptors. We demonstrate that morphine binds to an accessory protein of Toll-like receptor 4 (TLR4), myeloid differentiation protein 2 (MD-2), thereby inducing TLR4 oligomerization and triggering proinflammation. Small-molecule inhibitors, RNA interference, and genetic knockout validate the TLR4/MD-2 complex as a feasible target for beneficially modifying morphine actions. Disrupting TLR4/MD-2 protein–protein association potentiated morphine analgesia in vivo and abolished morphine-induced proinflammation in vitro, the latter demonstrating that morphine-induced proinflammation only depends on TLR4, despite the presence of opioid receptors. These results provide an exciting, nonconventional avenue to improving the clinical efficacy of opioids.

  • protein–protein interaction
  • pain management therapy
  • drug discovery

Footnotes

  • 1To whom correspondence should be addressed. E-mail: Hubert.Yin{at}colorado.edu.
  • Author contributions: X.W., L.C.L., K.R., A.A.S., M.R.H., L.R.W., and H.Y. designed research; X.W., L.C.L., K.R., A.J.d.J., J.T., K.C., and A.R. performed research; X.W., L.C.L., K.R., A.J.d.J., J.T., K.C., A.A.S., M.R.H., L.R.W., and H.Y. analyzed data; and X.W., L.C.L., K.R., M.R.H., L.R.W., and H.Y. wrote the paper.

  • The authors declare no conflict of interest.

  • *This Direct Submission article had a prearranged editor.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1200130109/-/DCSupplemental.

Citation:

X. Wang, L. C. Loram, K. Ramos, A. J. de Jesus, J. Thomas, K. Cheng, A. Reddy, A. A. Somogyi, M. R. Hutchinson, L. R. Watkins, and H. Yin, Morphine activates neuroinflammation in a manner parallel to endotoxin. PNAS 109, 6325-6330 (2012).

International Union of Basic and Clinical Pharmacology. XCVI. Pattern Recognition Receptors in Health and Disease
C. E. Bryant, S. Orr, B. Ferguson, M. F. Symmons, J. P. Boyle, and T. P. Monie
Pharmacol. Rev. 67, 462-504 (31 March 2015)

Chronic Morphine-Induced MicroRNA-124 Promotes Microglial Immunosuppression by Modulating P65 and TRAF6
S. Qiu, Y. Feng, G. LeSage, Y. Zhang, C. Stuart, L. He, Y. Li, Y. Caudle, Y. Peng, D. Yin et al.
J. Immunol. 194, 1021-1030 (1 February 2015)

Interactive HIV-1 Tat and Morphine-Induced Synaptodendritic Injury Is Triggered through Focal Disruptions in Na+ Influx, Mitochondrial Instability, and Ca2+ Overload
S. Fitting, P. E. Knapp, S. Zou, W. D. Marks, M. S. Bowers, H. I. Akbarali, and K. F. Hauser
J. Neurosci. 34, 12850-12864 (17 September 2014)

Impact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women
A. S. Reece, and G. K. Hulse
BMJ Open 4, e004521-e004521 (2 June 2014)

A Monoclonal Antibody Specific for 6-Monoacetylmorphine Reduces Acute Heroin Effects in Mice
I. L. Bogen, F. Boix, E. Nerem, J. Morland, and J. M. Andersen
J. Pharmacol. Exp. Ther. 349, 568-576 (1 June 2014)

Morphine stimulates platelet-derived growth factor receptor-{beta} signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo
M. L. Weber, C. Chen, Y. Li, M. Farooqui, J. Nguyen, T. Poonawala, R. P. Hebbel, and K. Gupta
Br J Anaesth 111, 1004-1012 (1 December 2013)

Mast cell activation contributes to sickle cell pathobiology and pain in mice
L. Vincent, D. Vang, J. Nguyen, M. Gupta, K. Luk, M. E. Ericson, D. A. Simone, and K. Gupta
Blood 122, 1853-1862 (12 September 2013)

Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain
X. Wang, P. M. Grace, M. N. Pham, K. Cheng, K. A. Strand, C. Smith, J. Li, L. R. Watkins, and H. Yin
FASEB J. 27, 2713-2722 (1 July 2013)

Adolescent Morphine Exposure Affects Long-Term Microglial Function and Later-Life Relapse Liability in a Model of Addiction
J. M. Schwarz, and S. D. Bilbo
J. Neurosci. 33, 961-971 (16 January 2013)

Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
M. R. Hutchinson, A. L. Northcutt, T. Hiranita, X. Wang, S. S. Lewis, J. Thomas, K. van Steeg, T. A. Kopajtic, L. C. Loram, C. Sfregola et al.
J. Neurosci. 32, 11187-11200 (15 August 2012)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882